Robert Cyran

Capital markets

La gloire des jeux

Why the biotechs outpace big pharma

When tech company mergers make sense

It’s better to give than to receive

A harder ride for R&D

Rentokil seeks to stop the rot

Banking

Breakingviews: Where drugs fail, M&A might prove a healthy course